Get the Stockscreener App
2.57
5.76%
0.14
After Hours:
2.52
-0.05
-1.95%
InspireMD Inc. Stock (NSPR) Forecast
The InspireMD Inc. (NSPR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.5316, representing a -1.49% decrease from the current price of $2.57. The highest analyst price target is $3.1703, and the lowest is $1.893.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NSPR Price Target
Average 1.7335
(-32.55% Downside)
Is InspireMD Inc. (NSPR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.22 | Neutral |
| STOCH(9,6) | 35.10 | Neutral |
| STOCHRSI(14) | 29.70 | Neutral |
| MACD(12,26) | -0.054 | Sell |
| ADX(14) | 18.64 | Neutral |
| William %R | -73.55 | Neutral |
| CCI(14) | -129.00 | Sell |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.7074
Sell
|
2.6579
Sell
|
| MA20 |
2.7042
Sell
|
2.7097
Sell
|
| MA50 |
2.8115
Sell
|
2.741
Sell
|
| MA100 |
2.6985
Sell
|
2.7188
Sell
|
| MA200 |
2.6148
Sell
|
2.71
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NSPR could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on NSPR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.22 indicates that NSPR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.1 indicates that NSPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 29.7 indicates that NSPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.64 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -129 indicates that NSPR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NSPR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about InspireMD Inc. financial reports and earnings history, InspireMD Inc. (NSPR) stock could reach $2.126 by 2030, $0.9725 by 2040 and $2.884 by 2050. See the projected annual prices until 2050 of the InspireMD Inc. stock below:
- InspireMD Inc. (NSPR) is expected to reach an average price of $1.606 in 2035, with a high prediction of $1.9025 and a low estimate of $1.936. This indicates an $-37.51% rise from the last recorded price of $2.57.
- InspireMD Inc. (NSPR) stock is projected to chart a bullish course in 2040, with an average price target of $1.1425, representing an $-55.54% surge from its current level. The forecast ranges from a conservative $0.9783 to a sky-high $0.9725.
- Our analysts predict InspireMD Inc. (NSPR) to jump 5.26% by 2045, soaring from $2.4842 to an average price of $2.7053, potentially reaching $2.5153. While $2.4842 is the low estimate, the potential upside is significant.
- InspireMD Inc. (NSPR) stock is expected to climb by 2050, reaching an average of $3.044, a $18.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.884 and $2.9126, respectively, highlighting the market's uncertainty.
InspireMD Inc. Stock (NSPR) Year by Year Forecast
InspireMD Inc. Stock (NSPR) Price Forecast for 2025
InspireMD Inc. Stock (NSPR) is expected to reach an average price of $1.9173 in 2025, with a high prediction of $3.538 and a low estimate of $0.2966. This indicates an -25.40% fall from the last recorded price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $2.0037 | $1.893 | $3.1703 | -22.04% |
| March, 2025 | $1.8465 | $1.5865 | $2.4651 | -28.15% |
| April, 2025 | $2.6401 | $1.7873 | $2.9401 | +2.73% |
| May, 2025 | $2.348 | $2.343 | $2.7749 | -8.64% |
| June, 2025 | $2.3359 | $2.1059 | $2.4864 | -9.11% |
| July, 2025 | $2.0294 | $1.8587 | $2.3355 | -21.03% |
| August, 2025 | $1.7855 | $1.5209 | $2.0501 | -30.53% |
| September, 2025 | $0.4615 | $0.3302 | $1.7372 | -82.04% |
| October, 2025 | $0.7087 | $0.2966 | $1.0311 | -72.43% |
| November, 2025 | $1.1844 | $0.6352 | $1.7415 | -53.91% |
| December, 2025 | $1.8616 | $0.9873 | $2.2301 | -27.57% |
InspireMD Inc. Stock (NSPR) Price Forecast for 2026
The predicted value for InspireMD Inc. (NSPR) in 2026 is set at an average of $2.2288. Estimates vary from a peak of $3.2259 to a trough of $1.2317, indicating an -13.28% surge from the present price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.5973 | $1.5344 | $3.0944 | +1.06% |
| February, 2026 | $2.643 | $2.1701 | $2.873 | +2.84% |
| March, 2026 | $2.8787 | $2.3703 | $3.0587 | +12.01% |
| April, 2026 | $2.8759 | $2.2371 | $3.2259 | +11.90% |
| May, 2026 | $2.8266 | $2.2688 | $3.1516 | +9.99% |
| June, 2026 | $1.6974 | $1.5859 | $2.8619 | -33.95% |
| July, 2026 | $2.2045 | $1.2831 | $2.2445 | -14.22% |
| August, 2026 | $2.3403 | $1.806 | $2.6403 | -8.94% |
| September, 2026 | $2.037 | $1.9474 | $2.4758 | -20.74% |
| October, 2026 | $1.7031 | $1.7031 | $2.1908 | -33.73% |
| November, 2026 | $1.7389 | $1.5674 | $1.956 | -32.34% |
| December, 2026 | $1.2808 | $1.2317 | $1.7602 | -50.16% |
InspireMD Inc. Stock (NSPR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for InspireMD Inc. (NSPR) is $1.4593, with a high forecast of $2.9139 and a low forecast of $0.0048. This indicates an -43.22% decrease from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0894 | $0.0048 | $0.2729 | -96.52% |
| February, 2027 | $0.378 | $0.00584 | $0.7004 | -85.29% |
| March, 2027 | $0.7969 | $0.3052 | $1.4123 | -68.99% |
| April, 2027 | $1.5373 | $0.6609 | $1.9052 | -40.18% |
| May, 2027 | $2.2759 | $1.2116 | $2.7716 | -11.44% |
| June, 2027 | $2.2767 | $1.8502 | $2.5867 | -11.41% |
| July, 2027 | $2.2953 | $2.2488 | $2.8253 | -10.69% |
| August, 2027 | $2.5639 | $1.9229 | $2.9139 | -0.24% |
| September, 2027 | $2.2146 | $1.9589 | $2.8424 | -13.83% |
| October, 2027 | $1.4932 | $1.2789 | $2.3297 | -41.90% |
| November, 2027 | $1.9018 | $0.9796 | $1.9418 | -26.00% |
| December, 2027 | $1.9369 | $1.5039 | $2.3404 | -24.63% |
InspireMD Inc. Stock (NSPR) Price Forecast for 2028
In 2028, InspireMD Inc. (NSPR) is projected to reach an average price of $1.3133, with a high projection of $2.6018 and a low estimate of $0.0247. This indicates an -48.90% fall from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.7407 | $1.6511 | $2.0868 | -32.27% |
| February, 2028 | $1.4097 | $1.4097 | $1.8953 | -45.15% |
| March, 2028 | $1.2205 | $1.2006 | $1.664 | -52.51% |
| April, 2028 | $0.9444 | $0.9044 | $1.2726 | -63.25% |
| May, 2028 | $0.3112 | $0.1927 | $0.1813 | -87.89% |
| June, 2028 | $0.1302 | $0.0247 | $0.3697 | -94.93% |
| July, 2028 | $0.4698 | $0.223 | $1.083 | -81.72% |
| August, 2028 | $1.056 | $0.3345 | $1.5802 | -58.91% |
| September, 2028 | $2.0474 | $0.8888 | $2.4488 | -20.33% |
| October, 2028 | $1.9589 | $1.5303 | $2.2689 | -23.78% |
| November, 2028 | $1.9832 | $1.6087 | $2.5103 | -22.83% |
| December, 2028 | $2.1446 | $1.8193 | $2.6018 | -16.55% |
InspireMD Inc. Stock (NSPR) Price Forecast for 2029
The 2029 price forecast for InspireMD Inc. Stock (NSPR) is $1.2707 on average, with a high prediction of $2.5333 and a low estimate of $0.00813. This represents an -50.56% decrease from the previous price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6835 | $1.519 | $2.5333 | -34.49% |
| February, 2029 | $1.3504 | $0.9719 | $1.6519 | -47.45% |
| March, 2029 | $1.4219 | $0.6762 | $1.639 | -44.67% |
| April, 2029 | $1.6378 | $1.3948 | $2.0405 | -36.27% |
| May, 2029 | $1.5677 | $1.3277 | $1.7891 | -39.00% |
| June, 2029 | $1.1992 | $0.9892 | $1.5843 | -53.34% |
| July, 2029 | $0.9306 | $0.9107 | $1.372 | -63.79% |
| August, 2029 | $0.4584 | $0.5284 | $0.9835 | -82.16% |
| September, 2029 | $0.644 | $0.6213 | $0.5141 | -74.94% |
| October, 2029 | $0.1538 | $0.1062 | $0.7538 | -94.02% |
| November, 2029 | $0.098 | $0.00813 | $0.4274 | -96.19% |
| December, 2029 | $0.7325 | $0.1317 | $1.2553 | -71.50% |
InspireMD Inc. Stock (NSPR) Price Forecast for 2030
InspireMD Inc. Stock (NSPR) is expected to reach an average price of $1.2607 in 2030, with a high forecast of $2.2898 and a low forecast of $0.2316. This signifies an -50.95% decrease from the last price of $2.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2904 | $0.566 | $2.126 | -49.79% |
| February, 2030 | $1.9447 | $1.2939 | $2.0047 | -24.33% |
| March, 2030 | $1.669 | $1.2945 | $2.1954 | -35.06% |
| April, 2030 | $1.8332 | $1.5073 | $2.2898 | -28.67% |
| May, 2030 | $1.3757 | $1.2112 | $2.2241 | -46.47% |
| June, 2030 | $1.0456 | $0.6648 | $1.3448 | -59.32% |
| July, 2030 | $1.3935 | $0.3727 | $1.5329 | -45.78% |
| August, 2030 | $1.3378 | $1.2678 | $1.7406 | -47.95% |
| September, 2030 | $1.2721 | $1.0321 | $1.4914 | -50.50% |
| October, 2030 | $0.9101 | $0.6964 | $1.2894 | -64.59% |
| November, 2030 | $0.5543 | $0.3643 | $0.9971 | -78.43% |
| December, 2030 | $0.7941 | $0.2316 | $0.7341 | -69.10% |
0.64%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):